{
    "paper_id": "PMC7241045",
    "metadata": {
        "title": "Arene\u2013Ruthenium(II) Complexes Containing 11H-Indeno[1,2-b]quinoxalin-11-one\nDerivatives and Tryptanthrin-6-oxime: Synthesis, Characterization,\nCytotoxicity, and Catalytic Transfer Hydrogenation of Aryl Ketones",
        "authors": [
            {
                "first": "Vladislava\nV.",
                "middle": [],
                "last": "Matveevskaya",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Dmitry",
                "middle": [
                    "I."
                ],
                "last": "Pavlov",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Taisiya",
                "middle": [
                    "S."
                ],
                "last": "Sukhikh",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Artem",
                "middle": [
                    "L."
                ],
                "last": "Gushchin",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Alexander",
                "middle": [
                    "Yu."
                ],
                "last": "Ivanov",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Tatiana",
                "middle": [
                    "B."
                ],
                "last": "Tennikova",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Vladimir",
                "middle": [
                    "V."
                ],
                "last": "Sharoyko",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Sergey",
                "middle": [
                    "V."
                ],
                "last": "Baykov",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Enrico",
                "middle": [],
                "last": "Benassi",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Andrei",
                "middle": [
                    "S."
                ],
                "last": "Potapov",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Chemistry\nof half-sandwich arene\u2013ruthenium(II) complexes\nhas been intensively investigated in the recent years, due to their\napplications in different areas such as catalysis and pharmacology.\nSuch complexes demonstrated high antiviral,1\u22123 antibiotic,3\u22126 and antitumor7\u221217 activity.",
            "cite_spans": [
                {
                    "start": 236,
                    "end": 237,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 238,
                    "end": 239,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 251,
                    "end": 252,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 253,
                    "end": 254,
                    "mention": "6",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 268,
                    "end": 269,
                    "mention": "7",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 270,
                    "end": 272,
                    "mention": "17",
                    "ref_id": "BIBREF8"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Ruthenium(II) coordination compounds also have been\nextensively\ninvestigated for their catalytic activity in transfer hydrogenation\nreactions18\u221227 and metathesis polymerization.28\u221230",
            "cite_spans": [
                {
                    "start": 141,
                    "end": 143,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 144,
                    "end": 146,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 177,
                    "end": 179,
                    "mention": "28",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 180,
                    "end": 182,
                    "mention": "30",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Arene\u2013ruthenium\ncomplexes have piano-stool type geometry\nwith pseudo-octahedral symmetry near the ruthenium(II) atom. The arene\nfragment stabilizes the complex and protects the Ru(II) metal center\nfrom oxidation to ruthenium(III). Aromatic ligands are relatively\ninert in substitution reactions and can be considered as spectator\nligands. The three remaining coordination sites opposite to the arene\nligand can be used to introduce a wide variety of ligands with N-,\nO-, S- or P-donor atoms. In the past decade, there has been a surge\nof interest in nitrogen-donor ligands for use in catalysis and bidentate\nligands have been very successful in this area.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Our group is\ninvolved in the research of polycyclic N-containing\nligands\u2014oximes of 11H-indeno[1,2-b]quinoxalin-11-one and its structural analogues.31 11H-Indeno[1,2-b]quinoxalin-11-one\noxime, often denoted in the literature as IQ1, and its sodium salt,\nIQ1S, were reported as potent c-Jun N-terminal kinase (JNK3) inhibitors,31,32 anti-inflammatory agents,33\u221235 neuroprotectors,36,37 and antitumor agents.38\u221240 Tryptanthrin demonstrates a wide\nrange of bioactivities,41,42 including antibacterial,43,44 antiviral,45 anticancer,46,47 and anti-inflammatory48 activity. However,\nthe coordination chemistry of such compounds is insufficiently explored.\nThere are only few examples of nickel(II) and cobalt(II) complexes\nwith 11H-indeno[1,2-b]quinoxalin-11-one\noxime, which to the best of our knowledge has never been employed\nbefore in the synthesis of any noble metal complexes. Such oxime ligands\nas 11H-indeno[1,2-b]quinoxalin-11-one\noxime in the presence of base (NEt3) can adopt up to eight\ndifferent coordination modes, leading to Ni(II) and Co(II) complexes\nwith nuclearities ranging from 1 to 8.49,50 11H-Indeno[1,2-b]quinoxalin-11-one oxime\nand its derivatives look promising in terms of stabilizing the complexes\ndue to \u03c0\u2013\u03c0 stacking interactions and its coordinating\nability. Herein, we report the first examples of arene\u2013Ru(II)\ncomplexes with 11H-indeno[1,2-b]quinoxalin-11-one\noximes and tryptanthrin-6-oxime, a derivative of natural alkaloid\ntryptanthrin. It was shown that such polycyclic oximes are capable\nof acting as chelating ligands, forming mono- and binuclear coordination\ncompounds.",
            "cite_spans": [
                {
                    "start": 147,
                    "end": 149,
                    "mention": "31",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 325,
                    "end": 327,
                    "mention": "31",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 328,
                    "end": 330,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 356,
                    "end": 358,
                    "mention": "33",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 359,
                    "end": 361,
                    "mention": "35",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 378,
                    "end": 380,
                    "mention": "36",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 381,
                    "end": 383,
                    "mention": "37",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 405,
                    "end": 407,
                    "mention": "38",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 408,
                    "end": 410,
                    "mention": "40",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 467,
                    "end": 469,
                    "mention": "41",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 470,
                    "end": 472,
                    "mention": "42",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 497,
                    "end": 499,
                    "mention": "43",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 500,
                    "end": 502,
                    "mention": "44",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 513,
                    "end": 515,
                    "mention": "45",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 527,
                    "end": 529,
                    "mention": "46",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 530,
                    "end": 532,
                    "mention": "47",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 554,
                    "end": 556,
                    "mention": "48",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 1099,
                    "end": 1101,
                    "mention": "49",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 1102,
                    "end": 1104,
                    "mention": "50",
                    "ref_id": "BIBREF45"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "The ligands\nused in this\nwork and their abbreviations are summarized in Scheme 1.",
            "cite_spans": [],
            "section": "Synthesis of the Complexes ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Complexes 1, 2, and 4 were\nprepared in high yield by the reaction between the commercially available\narene\u2013ruthenium dimer [Ru(p-cym)Cl2]2 and the appropriate ligand in methanol/dimethylformamide\n(DMF) mixture (complexes 1, 4) or methanol\n(complexes 2, 3). It was shown that even\nin the absence of a base, deprotonation of the oxime group occurs,\nand the ligands (HL1, HL2, and HL4) are coordinated in anionic form. It is worth noting that\ncomplex 3 could be obtained only in the presence of a\nbase. Complex 3 was prepared by the reaction between\n[Ru(p-cym)Cl2]2 and HL3 in methanol in the presence of KOH. Ligands HL1 and HL2 form mononuclear complexes of the typical piano-stool\ntype (Scheme 2).",
            "cite_spans": [],
            "section": "Synthesis of the Complexes ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Ligands HL3 and HL4 contain an additional nitrogen\natom; therefore,\nthey can form both mono- and binuclear complexes. Unexpectedly, the\nratio of the reagents did not affect the product composition: at a\nratio of Ru/HL3 2:1, ligand HL3 forms a binuclear complex 3 of composition [Ru2(p-cym)2(L3)Cl3], whereas at a ratio of 1:1\ninstead of a mononuclear complex, the product contains the same complex 3 and the initial ligand (Scheme 3).",
            "cite_spans": [],
            "section": "Synthesis of the Complexes ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Similarly, reaction between HL4 and [Ru(p-cym)Cl2]2 is not\naffected by reactants ratios. Regardless of the metal\u2013ligand\nratio, only mononuclear complex of the composition [Ru(p-cym) (L4)Cl] was obtained (Scheme 4). In this case, the formation of a dinuclear\ncomplex (via nitrogen donor atom in position 1 of\nthe tetracyclic system) is probably hindered by the repulsion between\nthe lone pair of the nitrogen atom in position 11 and bulky Ru(cym)\nfragment.",
            "cite_spans": [],
            "section": "Synthesis of the Complexes ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "All complexes are air-stable in the solid state; they\nare sparingly\nsoluble in chloroform, acetonitrile, and DMSO and almost insoluble\nin water and alcohols. The complexes were fully characterized by elemental\nanalysis, cyclic voltammetry, IR, NMR spectroscopy methods, and single-crystal\nX-ray diffraction.",
            "cite_spans": [],
            "section": "Synthesis of the Complexes ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Coordination of anionic forms of the ligands HL1\u2013HL4 with strong electron-withdrawing indeno[1,2-b]quinoxaline\nor tryptanthrin cores may be due to increased acidity of these ligands\ncompared to the oximes of aliphatic or aromatic ketones, leading to\nincreased concentration of their anionic forms. Thermochemical density\nfunctional theory (DFT) calculations were carried out in order to\ncompare the thermodynamic stability of the complex 1 and its hypothetical\nform with the neutral coordinated HL1 ligand. Two reactions of formation of both of the complexes\nwere considered12",
            "cite_spans": [],
            "section": "Synthesis of the Complexes ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Free-energy\nand enthalpy changes were calculated at M062X 6-311+G(2d,p)/LANL2DZ\nlevel of theory, and solvent (DMF) effects were taken into account\nusing SMD model. It was found that the formation of the complex with\nthe anionic form is more thermodynamically favorable (\u0394G1 = \u221294.9 kJ/mol; \u0394G2 = \u221216.3 kJ/mol; \u0394H1 = \u221297.6 kJ/mol; \u0394H2 = \u221210.8 kJ/mol).",
            "cite_spans": [],
            "section": "Synthesis of the Complexes ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Complexes 1\u20134 crystallize in a monoclinic crystal system having\na single formula\nunit as an asymmetric unit. Phase purity of the obtained products\nwas confirmed by powder X-ray diffraction analysis (see the Supporting Information). In mononuclear complexes 1, 2, and 4, ruthenium coordinates\ncymene molecule in a \u03b76 fashion, which is considered\nto occupy three coordination sites of a quasi-octahedral arrangement.\nThe other three sites are occupied by a chlorine atom and two nitrogen\natoms of the deprotonated oximate ligands coordinated in a bidentate\nfashion forming a five-membered chelate ring (Figures 1\u20133). It should be noted that in most of the structurally characterized\narene\u2013ruthenium complexes with heterocyclic oximes, the N,N-coordinated\nligands remain neutral51\u221254 and so far only one example of deprotonated 2-pyridyl cyanoxime\nwas reported.51",
            "cite_spans": [
                {
                    "start": 775,
                    "end": 777,
                    "mention": "51",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 778,
                    "end": 780,
                    "mention": "54",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 858,
                    "end": 860,
                    "mention": "51",
                    "ref_id": "BIBREF46"
                }
            ],
            "section": "X-ray Crystal Structures ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 601,
                    "end": 610,
                    "mention": "Figures 1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 611,
                    "end": 612,
                    "mention": "3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "The interatomic Ru\u2013N distances involving\noxime and heterocyclic\nnitrogen atoms are in the ranges of 2.08\u20132.10 and 2.12\u20132.16\n\u00c5 and somewhat greater than the corresponding values typical\nfor oxime\u2013ruthenium complexes (1.95\u20132.04 and 1.95\u20132.08\n\u00c5), probably due to bulkiness of the ligands. The interatomic\nRu\u2013Cl distances of about 2.40 \u00c5 and Ru\u2013C distances\nin the range 2.17\u20132.26 \u00c5 are close to typically found\nin arene\u2013ruthenium complexes. All three complexes have chiral\nmetal centers, but crystallize in a centrosymmetric space group, and\nthus, enantiomer resolution was not possible.",
            "cite_spans": [],
            "section": "X-ray Crystal Structures ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Compound 3 is a binuclear complex that crystallizes\nin a centrosymmetric monoclinic C2/c space group (Figure 4). Arrangement of one of ruthenium atoms is similar to mononuclear\ncomplexes described above\u2014it consists of two nitrogen atoms\nof deprotonated oxime ligand HL3, chloride ion and p-cymene molecule, interatomic\ndistances between ruthenium and donor atoms are also close to the\nones observed for mononuclear complexes. The second ruthenium atom\nis achiral and coordinates one cymene molecule, two chloride ions,\nand a nitrogen atom in position 2 of ligand HL3.",
            "cite_spans": [],
            "section": "X-ray Crystal Structures ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 102,
                    "end": 110,
                    "mention": "Figure 4",
                    "ref_id": "FIGREF3"
                }
            ]
        },
        {
            "text": "In complexes 1 and 2 the\nheterocyclic\noxime ligands are involved in \u03c0\u2013\u03c0 stacking with\nintermolecular distances 3.379(3) and 3.384(2) \u00c5 correspondingly\n(Figures S1 and S2). In compound 4, the molecules of ligand HL4 cannot align in parallel planes due to the presence of lattice\nDMF molecules. In this case, each of HL4 molecules is involved in four CH\u00b7\u00b7\u00b7N short\ncontacts with interatomic H\u00b7\u00b7\u00b7N distances of 2.658\nand 2.741 \u00c5 (Figure S3).",
            "cite_spans": [],
            "section": "X-ray Crystal Structures ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "In\norder to provide a quantum mechanical foundation to the experimental\nobservations, the analysis of the non-covalent interaction (NCI) isosurfaces\nwas performed both on monomers and dimers of compounds 1, 2, and 4 (Figure S4). The intramolecular interactions that are mainly responsible\nfor the stabilization of the monomers (blue areas) involve hydrogen\natoms, which are involved in attractive interactions with the two\noxygen atoms, carbon atoms, and with the chlorine atom. Concerning\ndimers, the main contribution to the stabilization of 12 and 22 is a wide \u03c0\u2013\u03c0 interaction between two ligands;\nthe case of 42 is rather different,\nby involving four punctual but more attractive interactions between\nhydrogen atoms of one ligand and nitrogen atoms of the other ligand\nmolecule (Figure S4).",
            "cite_spans": [],
            "section": "X-ray Crystal Structures ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Thermodynamic\npreference of N,N-bidentate over N,O-bidentate coordination\nmode of the ligand L1 was confirmed\nby DFT calculations. Both in the gas phase and DMF N,N-coordination\nof the deprotonated ligand L1 with the formation of a five-membered ring is about 19 kJ/mol more\nfavorable (Figure S5).",
            "cite_spans": [],
            "section": "X-ray Crystal Structures ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Two possible\norientations of the cymene ligand\u2014one with\nisopropyl group close to the oxime fragment and the other with the\nopposite orientation\u2014methyl group facing the oxime were evaluated\nby DFT calculations (Figure S6). It was\nfound that the first orientation is about 8 kJ/mol more stable than\nthe second one consistent with the X-ray crystal structures. Despite\nthe proximity of the bulky isopropyl group and the oxime fragment,\nthis form is more stable probably due to the repulsion of the isopropyl\ngroup and the aromatic part of the HL1 ligand in the structure with\nthe opposite cymene orientation.",
            "cite_spans": [],
            "section": "X-ray Crystal Structures ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "The IR spectra of free\nneutral ligands display broad bands in the range 3200\u20133250\ncm\u20131 due to OH stretching vibrations and bands in\nthe range 1640\u20131630 cm\u20131 due to C=N\nstretching vibrations. Upon coordination OH stretching bands disappear,\nwhereas C=N stretching bands shift to 1625\u20131600 cm\u20131, in accordance with the deprotonation of the ligands\nand their coordination to the metal center in N,N\u2032-bidentate chelating fashion.",
            "cite_spans": [],
            "section": "Spectroscopic Characterization ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "The 1H NMR spectra of complexes 1\u20134 recorded in DMSO-d6 display all of the expected signals of the\ncoordinated p-cymene and N,N\u2032-ligand. The\nresonances of the N,N\u2032-ligand atoms are shifted upfield with\nrespect to those of uncoordinated ligands, confirming its coordination\nto the ruthenium(II) center. The chirality of ruthenium center in\nthe complexes induces significant changes to the NMR signals of the p-cymene moiety in complexes 1\u20134. The 1H NMR spectra of 1, 2, and 4 exhibit a doublet of doublets for the methyl groups in the\nisopropyl moiety, and four doublets attributable to the protons of p-cymene ring in the range of 5.5\u20136.3 ppm, which\nis typical of ruthenium\u2013arene systems with an asymmetric ruthenium\ncenter.55,56 The 1H NMR spectra of binuclear\ncomplex 3 exhibit two doublets of doublets for the methyl\ngroups in the isopropyl moiety, and eight doublets attributable to\nthe p-cymene protons in the range of 5.3\u20136.2\nppm. There is no signal of the oxime proton in the spectra of all\ncomplexes, which confirms the coordination of the ligand in the anionic\nform. All complexes demonstrate resonances in the range typical of\nrelated compounds and in accordance with the existence of only one\nspecies in solution.",
            "cite_spans": [
                {
                    "start": 724,
                    "end": 726,
                    "mention": "55",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 727,
                    "end": 729,
                    "mention": "56",
                    "ref_id": "BIBREF51"
                }
            ],
            "section": "Spectroscopic Characterization ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "UV\u2013vis spectrum of complex 1 (Figure S7) in acetonitrile demonstrates\na complex shape that\ncan be deconvoluted into five Gaussian bands (Figure S8). In order to gain insight into the origin of the\nabsorption bands, time-dependent DFT calculations were carried out\n(Figure S9). The main features of the singlet\nexcited states showing the highest values of oscillator strength (f) together with the experimental positions of deconvoluted\nGaussian bands are given in Table 1. Because of the complexity of the transition nature\nin terms of MOs elementary transitions, the natural transition orbital\n(NTO) analysis was also carried out. As it can be seen from the transition\ndiagrams, all of the absorption bands are of mixed character and correspond\nto both local and charge transfer excitations. Although the nature\nof the longer absorption transitions (500\u2013260 nm) is charge\ntransfer, calculations performed by employing long-range corrected\nhybrid functionals (viz. CAM-B3LYP and \u03c9-B97X[D])\ndid not show a significant improvement in the match with the experimental\nvalues with respect to the B3LYP functional; on the contrary, for\nthe short wavelength region transitions (200\u2013230 nm), \u03c9-B97X[D]\ndemonstrated a good performance.",
            "cite_spans": [],
            "section": "Spectroscopic Characterization ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "To study the redox properties\nof mononuclear and binuclear complexes 1 and 3 in solution, cyclic voltammograms were recorded at room temperature\nand a scan rate of 0.1 V/s using a 0.1 M solution of Bu4NPF6 in DMF (Figures S10 and S11). The corresponding values E1/2 of the\nredox potentials are shown in Table 2. In the positive region, an anodic peak was detected\nat +1.30 and +1.37 V (versus Ag/AgCl) for complexes 1 and 3, respectively. These irreversible processes apparently\ncorrespond to the oxidation of Ru(II) to Ru(III). This is consistent\nwith the fact that the highest occupied molecular orbital in 1 is partially localized on the ruthenium atom (8,5%, Table S1). Sufficiently high oxidation potentials\nare consistent with the \u03c0-acceptor properties of heterocyclic\noxime and p-cymene ligands. Ru-centered oxidation\nin the region from +1.0 to +1.5 V (vs Ag/AgCl) was also found for\nsimilar p-cymene complexes of Ru(II).57,58 The irreversibility of this process is probably due to the instability\nof the p-cymene\u2013Ru(III) species and the removing\nof the p-cymene fragment. This is evidenced by the\nelongation of Ru\u2013C bonds and a loss in energy during the transition\nfrom Ru(II) complex to Ru(III) complex according to DFT calculations.",
            "cite_spans": [
                {
                    "start": 928,
                    "end": 930,
                    "mention": "57",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 931,
                    "end": 933,
                    "mention": "58",
                    "ref_id": "BIBREF53"
                }
            ],
            "section": "Cyclic Voltammetry Studies ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "A number of irreversible processes\nwere detected in the negative\nregion both for complexes 1 and 3, probably\nrelated to the reduction of the heterocyclic oxime ligand. This is\nconsistent with the composition of lowest unoccupied molecular orbital\nin 1, which mainly consists of the oxime ligand orbitals\n(53%, Table S1). Similar irreversible reduction\nprocesses shifted to a more cathodic region were also found in the\ncyclic voltammogram of the starting HL1 ligand in acetonitrile (Figure S12).",
            "cite_spans": [],
            "section": "Cyclic Voltammetry Studies ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "We have tested the catalytic\nactivity of complexes for the selective hydrogenation of aryl ketones\nusing 2-propanol as both the reducing agent and solvent in the presence\nof NaOH as the base. Reaction between isopropyl alcohol and acetophenone\nwas chosen as a model reaction (Scheme 5).",
            "cite_spans": [],
            "section": "Catalytic Activity Studies ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Reduction of acetophenone did not go to completion\n(Table 3), which can\nbe explained by\nthe reversibility of hydrogen transfer. Conversion versus time plots\nfor complexes 1\u20134 are shown in Figure 5. Complex 1 demonstrated\nthe best catalytic activity, providing 93% conversion after 1 h. Other\ncomplexes (2\u20134) gave \u223c50%\nconversions after 1\u20132 h, and nearly full conversion for catalysts 2 and 3 was achieved in 6 h.",
            "cite_spans": [],
            "section": "Catalytic Activity Studies ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 188,
                    "end": 196,
                    "mention": "Figure 5",
                    "ref_id": "FIGREF4"
                }
            ]
        },
        {
            "text": "Encouraged by the potential\nof complex 1, we were\ninterested to test this complex for transfer hydrogenation of substituted\naryl ketones (Scheme 5), and complex 1 was found to exhibit good catalytic\nactivity and functional groups tolerance (Table 4).",
            "cite_spans": [],
            "section": "Catalytic Activity Studies ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Conversion versus time plots for\nthe five ketones (Table 4, entries 2\u20136) are shown\nin Figure 6. It was\nshown that ketones with electron-donating groups reacted faster. It\nmight be due to the increase of the electron density on the carbon\natom of the carbonyl group, which favorably affects the coordination\nof the carbonyl group to ruthenium(II) center. In turn, electron-withdrawing\nsubstituents (Table 4, entries 6, 7) reduce the electron density on the carbonyl group\nof the substrate, which makes coordination to the ruthenium(II) more\ndifficult, which results in the decrease of the reaction rate.",
            "cite_spans": [],
            "section": "Catalytic Activity Studies ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 86,
                    "end": 94,
                    "mention": "Figure 6",
                    "ref_id": "FIGREF5"
                }
            ]
        },
        {
            "text": "High chemoselectivity of the reduction process was noted: nitro\ngroups (Table 4, entries\n6, 7) remain unchanged under the hydrogenation conditions. For ketone\nwith the double C=C bond conjugated to the carbonyl group (Table 4, entry 8), only ketone\nmoiety undergoes transformation. Moreover, high yields can also be\nachieved in case of 4-bromooacetophenone hydrogenation (Table 4, entry 5), with no evidence\nof dehydrobromination or ring reduction. It is worth noting that a\nheteroaromatic ketone can also be reduced (Table 4, entry 10). Pyridine moiety can potentially\nbind to ruthenium center and inhibit the catalytic reaction; however,\n2-acetylpyridine (Table 4, entry 10) was rapidly hydrogenated.",
            "cite_spans": [],
            "section": "Catalytic Activity Studies ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Pancreatic\ncancer is one of the most aggressive\nand deadly types of cancer. The increasing resistance of the pancreatic\ncancer to effective chemotherapy has become an urgent problem.59 Therefore, the obtained complexes were screened\nat different concentrations for their ability to affect the cell viability\nof human adenocarcinoma cell line PANC-1 over noncancerous human retinal\npigment epithelial cell line ARPE-19. The cytotoxic activity of the\ncomplexes was analyzed by cell viability MTT assay.",
            "cite_spans": [
                {
                    "start": 182,
                    "end": 184,
                    "mention": "59",
                    "ref_id": "BIBREF54"
                }
            ],
            "section": "Cytotoxicity ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "As it is\nshown in Figure 7,\ncomplexes 1\u20133 demonstrate moderate cytotoxic effect\ntoward PANC-1 but practically no cytotoxic effect ARPE-19 cell lines.\nComplex 2 at the concentrations of 30 and 90 \u03bcM\ndecreased cell viability for PANC-1 cell line to 95 and 70%, respectively.\nComplex 4 at the concentrations 0.3, 30, and 90 \u03bcM\ndecreased cell viability for PANC-1 cell line to 55, 40, and 55%,\nrespectively. It can be concluded that complexes 2 and 4 have mild cytotoxic activity for cancer human cell lines.\nNevertheless, the cytotoxicity of the studied complexes is significantly\ninferior to the cytotoxicity of drugs widely used in clinical practice\nfor the chemotherapeutical treatment of pancreatic adeonocarcinoma,\nthat is, fluorouracil (IC50 3.85 \u03bcM) and gemcitabine\n(IC50 27 nM).60 It is interesting\nto note that at low concentrations of the complexes viability of the\ncells increased (relative to control) despite the known cytotoxic\npotential of arene\u2013ruthenium core. This is probably due to\nthe JKN3-inhibitive activity of the oxime ligands discovered recently,31 which limit the cell apoptosis process.",
            "cite_spans": [
                {
                    "start": 783,
                    "end": 785,
                    "mention": "60",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 1068,
                    "end": 1070,
                    "mention": "31",
                    "ref_id": "BIBREF24"
                }
            ],
            "section": "Cytotoxicity ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 18,
                    "end": 26,
                    "mention": "Figure 7",
                    "ref_id": "FIGREF6"
                }
            ]
        },
        {
            "text": "Ruthenium(II)\u2013arene\ncomplexes containing 11H-indeno[1,2-b]quinoxalin-11-one derivatives and\ntryptanthrin-6-oxime were prepared and their catalytic, biological,\nand electrochemical properties were evaluated. The crystal structures\nof all complexes display a typical piano-stool geometry with ligands\nN,N\u2032-coordinated to the ruthenium in each case.",
            "cite_spans": [],
            "section": "Conclusions",
            "ref_spans": []
        },
        {
            "text": "Our research\nalso shows that arene\u2013ruthenium(II) complexes\nwith 11H-indeno[1,2-b]quinoxalin-11-one\nderivatives and tryptanthrin-6-oxime are effective catalysts for the\ntransfer hydrogenation reaction. These complexes tolerate a range\nof functional groups and catalyze the reaction, giving target alcohols\nin high yields. Ruthenium complexes with tryptanthrin-6-oxime and\n6H-indeno[1,2-b]pyrido[3,2-e]pyrazin-6-one oxime demonstrated mild cytotoxic activity\nfor human adenocarcinoma cell line PANC-1.",
            "cite_spans": [],
            "section": "Conclusions",
            "ref_spans": []
        },
        {
            "text": "The dimer [Ru(p-cym)Cl2]2 was purchased from Alfa Aesar. The\nligands 11H-indeno[1,2-b]quinoxalin-11-one\noxime (HL1), 6-(hydroxyimino)indolo[2,1-b]quinazolin-12(6H)-one (tryptanthrin-6-oxime, HL2), 10H-indeno[1,2-b]pyrido[3,4-e]pyrazin-10-one oxime (HL3), and 6H-indeno[1,2-b]pyrido[3,2-e]pyrazin-6-oneoxime (HL4) were prepared as previously described.36 All other materials were obtained from commercial\nsources and were used as received.",
            "cite_spans": [
                {
                    "start": 351,
                    "end": 353,
                    "mention": "36",
                    "ref_id": "BIBREF29"
                }
            ],
            "section": "Materials\nand Methods ::: Experimental Section",
            "ref_spans": []
        },
        {
            "text": "IR spectra were recorded\non an Agilent Cary 630 FTIR spectrometer quipped with a diamond attenuated\ntotal reflectance tool from 700 to 3500 cm\u20131. NMR\nspectroscopic data were recorded with a Brucker AVANCE III 400 spectrometer\n(400.13 MHz for 1H and 100.61 MHz for 13C) and\nwere referenced to residual solvent signal.",
            "cite_spans": [],
            "section": "Materials\nand Methods ::: Experimental Section",
            "ref_spans": []
        },
        {
            "text": "Chromato-mass spectrometric\nanalysis was carried out using Agilent\n7890A gas chromatograph with Agilient 5975C mass-selective detector\nwith quadrupole mass-analyzer (electron impact ionization energy 70\neV). The injector temperature was maintained at 300 \u00b0C, and the\ninjection volume was 1 \u03bcL (split 40:1). The instrument was equipped\nwith a HP-5 ms capillary column of 30 m length, 0.25 mm i.d., and\n0.25 \u03bcm film thickness. The carrier gas was helium at a constant\nflow rate of 1 mL/min. The GC oven program started at 79 \u00b0C (1.0\nmin hold) ramped up to 300 \u00b0C (heating rate 13 \u00b0C/min) for\n10 min, total chromatogram time was 28 min. Transfer line temperature\nwas 300 \u00b0C, MS Source\u2014230 \u00b0C and MS Quadrouple\u2014150\n\u00b0C. The electron energy was 70 eV. From 0 to 4 min, the MS was\nswitched off (solvent delay). Data analysis and instrument control\nwas carried out with MSD 5975C software.",
            "cite_spans": [],
            "section": "Materials\nand Methods ::: Experimental Section",
            "ref_spans": []
        },
        {
            "text": "Cyclic voltammograms were recorded\nwith a 797 VA Computrace system (Metrohm, Switzerland). All measurements\nwere carried out at room temperature with a conventional three-electrode\nconfiguration consisting of glassy carbon working electrode, platinum\nauxiliary electrode, and Ag/AgCl/KCl reference electrode. The solvent\n(DMF or CH3CN) was deoxygenated before use. The solution\nof tetra-n-butylammonium hexafluorophosphate Bu4NPF6 (0.1 M) was used as a supporting electrolyte.\nThe concentrations of the compounds were 10\u20133 M.",
            "cite_spans": [],
            "section": "Cyclic Voltammetry ::: Experimental Section",
            "ref_spans": []
        },
        {
            "text": "Single-crystal X-ray diffraction\n(XRD) data for the compounds were collected by a Bruker Apex DUO diffractometer\nusing the graphite-monochromated Mo K\u03b1 radiation (\u03bb =\n0.71073 \u00c5). Absorption corrections were applied with the use\nof the SADABS program.61 The crystal structures\nwere solved and refined by means of the SHELXT62 and SHELXL63 programs using\nOLEX2 GUI.64 Atomic thermal displacement\nparameters for nonhydrogen atoms except for some solvate molecules\nwere refined anisotropically. The positions of H atoms were calculated\ncorresponding to their geometrical conditions and refined using the\nriding model. In 3, O atoms of one of solvate methanol\nmolecules was disordered over three positions with restrained C\u2013O\ndistances (DFIX) and occupancy of 0.33. H atoms of hydroxyl group\nof methanol molecules were not located but included in the formula\nof 3. The crystallographic data and details of the structure\nrefinements are summarized in Table 5. Crystallographic data for the structures 1\u20134 have been deposited with the Cambridge Crystallographic Data Centre\n(CCDC) as Supporting Information nos. 1974048\u20131974051.\nCopies of the data can be obtained free of charge on application to\nCCDC (http://www.ccdc.cam.ac.uk/data_request/cif).",
            "cite_spans": [
                {
                    "start": 250,
                    "end": 252,
                    "mention": "61",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 322,
                    "end": 324,
                    "mention": "62",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 335,
                    "end": 337,
                    "mention": "63",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 363,
                    "end": 365,
                    "mention": "64",
                    "ref_id": "BIBREF60"
                }
            ],
            "section": "X-ray Crystallography ::: Experimental Section",
            "ref_spans": []
        },
        {
            "text": "A typical transfer\nhydrogenation reaction was carried out under air as follows: to 0.05\nmmol of catalyst precursor contained in the reaction flask were added\nisopropyl alcohol (4 mL), NaOH (0.2 mmol) and acetophenone (1 mmol),\nin that order. The reaction mixture was stirred for 6 h at 82 \u00b0C.\nAfter that, reaction mass was analyzed by GC and GC\u2013MS. The\nperformed blank experiments confirmed that no products of reaction\nwere obtained unless the catalyst and NaOH were added.",
            "cite_spans": [],
            "section": "Catalytic Activity Determination ::: Experimental Section",
            "ref_spans": []
        },
        {
            "text": "PANC-1 (pancreatic adenocarcinoma)\nwere obtained from Russian Cell Culture Collection (Institute of Cytology\nRAS). ARPE-19 (ATCC CRL-2302 retinal pigment epithelial) cells were\nobtained from the American Type Culture Collection (ATCC) (Manassas,\nVA). PANC-1 and ARPE-19 cells were cultured in DMEM-F12 medium supplemented\nwith 10% fetal bovine serum, 100 units/mL penicillin, and 100 \u03bcg/mL\nstreptomycin, at 37 \u00b0C in a humidified atmosphere containing\n95% air and 5% CO2. The cytotoxicity of tested compounds\nwas studied using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium\nbromide (MTT) reduction assay as described previously.65 MTT-formazan crystals formed by metabolically\nactive cells were dissolved in dimethyl sulfoxide, and absorbance\nwas measured at 540 and 690 nm in Varioskan LUX Multimode Microplate\nReader (Thermo Scientific, USA). Values measured at 540 nm were subtracted\nfor background values at 690 nm, and the data were shown as a percent\nof control untreated samples.",
            "cite_spans": [
                {
                    "start": 633,
                    "end": 635,
                    "mention": "65",
                    "ref_id": "BIBREF61"
                }
            ],
            "section": "Cytotoxicity\nDetermination ::: Experimental Section",
            "ref_spans": []
        },
        {
            "text": "The calculations were\nperformed using Gaussian 09 package.66 Experimental\nX-ray structures of complex 1 was used as a starting\npoint for DFT geometry optimizations. Singlet state geometry optimizations\nwere carried out at the DFT level of theory employing the three-parameter\nhybrid B3LYP functional67\u221270 and 6-311+G(2d,p) basis set71\u221274 for the first and second-row\natoms, while LanL2DZ75,76 was used for the ruthenium atoms.\nSolvation effects were taken into account using the IEFPCM model77 and acetonitrile as solvent. Frequency calculations\nwere performed for the optimized geometries in order to establish\nthe nature of the stationary points. Lack of imaginary vibration modes\nfor the optimized structures indicate that the stationary points found\ncorresponded to minima on the potential energy surface. Time-dependent\nDFT calculations with Tamm\u2013Dancoff approximation78 were carried out using the same basis sets and\nB3LYP,67\u221270 CAM-B3LYP,79 and \u03c9-B97X[D]80 functionals. The nature of electronic transitions\nwas analyzed using the NTOs approach.81 The energies of the coordination isomers of complex 1 were compared after geometry optimization and calculation of vibrational\nfrequencies using M062X82 functional and\n6-311+G(2d,p)/LanL2DZ75,76 basis sets; solvation effects\nin dimethylformamide were taken into account using the SMD model.83",
            "cite_spans": [
                {
                    "start": 58,
                    "end": 60,
                    "mention": "66",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 299,
                    "end": 301,
                    "mention": "67",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 302,
                    "end": 304,
                    "mention": "70",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 332,
                    "end": 334,
                    "mention": "71",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 335,
                    "end": 337,
                    "mention": "74",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 387,
                    "end": 389,
                    "mention": "75",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 390,
                    "end": 392,
                    "mention": "76",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 491,
                    "end": 493,
                    "mention": "77",
                    "ref_id": "BIBREF74"
                },
                {
                    "start": 873,
                    "end": 875,
                    "mention": "78",
                    "ref_id": "BIBREF75"
                },
                {
                    "start": 929,
                    "end": 931,
                    "mention": "67",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 932,
                    "end": 934,
                    "mention": "70",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 945,
                    "end": 947,
                    "mention": "79",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 961,
                    "end": 963,
                    "mention": "80",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 1051,
                    "end": 1053,
                    "mention": "81",
                    "ref_id": "BIBREF79"
                },
                {
                    "start": 1204,
                    "end": 1206,
                    "mention": "82",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 1243,
                    "end": 1245,
                    "mention": "75",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 1246,
                    "end": 1248,
                    "mention": "76",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 1344,
                    "end": 1346,
                    "mention": "83",
                    "ref_id": "BIBREF81"
                }
            ],
            "section": "Computational Chemistry\nDetails ::: Experimental Section",
            "ref_spans": []
        },
        {
            "text": "HL1 (24.7 mg, 0.1\nmmol) was dissolved in DMF (1.5 mL), [Ru(p-cym)Cl2]2 (30.6 mg, 0.05 mmol) was dissolved in MeOH (1.5\nmL), and the resulting solution was added to the initial one. After\n24 h, red crystals formed were filtered off and washed twice with\nMeOH. Yield 43 mg (83%). 1H NMR (400 MHz, DMSO-d6): \u03b4 0.99 (d, 3H, Me-iPr, J = 8 Hz), 1.05 (d, 3H, Me-iPr, J = 8 Hz), 2.15 (s, 3H, Me-Ar), 2.64 (m, 1H,\nCH-Ar), 2.73 (s, Me-iPr), 5.76 (d, 1H, CH (p-cym), J = 4 Hz), 5.99 (d, 1H, CH (p-cym), J = 4 Hz), 6.03 (d, 1H, CH (p-cym), J = 8 Hz), 6.08 (d, 1H, CH (p-cym), J = 8 Hz), 7.53 (t, 1H, H2-L1, J = 8 Hz), 7.65 (t, 1H, H3-L1, J = 8 Hz), 7.93 (t, 1H, H1-L1, J = 4 Hz), 8.02 (t, 1H, H4-L1, J = 8 Hz), 8.08 (d, 1H, H9-L1, J = 8 Hz),\n8.18 (d, 1H, H8-L1, J = 8 Hz), 8.33 (d,\n1H, H10-L1, J = 2 Hz), 8.40 (d, 1H, H7-L1, J = 8 Hz) ppm. 13C NMR (100\nMHz, CDCl3): \u03b4 22.1 (Me-Ar), 22.5 (Me-iPr), 24.1 (Me-iPr), 31.2 (CH-iPr),\n80.9 (p-cym), 81.3 (p-cym), 83.7\n(p-cym), 84.1 (p-cym), 89.5 (p-cym), 103.7 (p-cym), 123.0 (L1), 123.4 (L1), 124.1 (L1), 126.3 (L1) 128.0 (L1), 128.4 (L1), 128.9 (L1), 130.3 (L1), 131.3 (L1), 132.0 (L1), 134.4 (L1), 140.2 (L1), 141.6 (L1), 148.0 (L1), 157.4 (L1) ppm. IR: 3075 (w),\n3059 (w), 3030 (w), 2963 (w), 2867 (w), 1604 (w), 1596 (m), 1497 (s),\n1468 (s), 1447 (m), 1420 (m), 1383 (m), 1356 (m), 1327 (m), 1303 (m),\n1244 (s), 1212 (m), 1199 (m), 1164 (m), 1140 (m), 1124 (s), 1092 (m),\n1068 (m), 1052 (m), 1034 (m), 1012 (m), 970 (m), 946 (m), 871 (s),\n794 (s), 765 (s), 749 (s), 725 (s). Found, %: C, 58.40; H, 4.41; N,\n8.32. C25H22N3OClRu. Calcd, %: C,\n58.08; H, 4.29; N, 8.13.",
            "cite_spans": [],
            "section": "[Ru(p-cym) (L1)Cl] (1) ::: Synthesis and Characterization ::: NCI Analysis by means of the Reduced Density\nGradient84ref84bibr\u221288ref88bibr was Performed on the Density of the Optimized Structures Using a\nHomemade Code ::: Experimental Section",
            "ref_spans": []
        },
        {
            "text": "HL2 (53 mg, 0.2 mmol)\nwas dissolved in MeOH (1.5 mL). [Ru(p-cym)Cl2]2 (61.2 mg, 0.1 mmol) was dissolved in MeOH (1.5\nmL), and the resulting solution was added to the initial one. After\n24 h, red crystals formed were filtered off and washed twice with\nMeOH. Yield 80 mg (75%). 1H NMR (400 MHz, CDCl3): \u03b4 1.08 (d, 3H, Me-iPr, J = 8 Hz), 1.11 (d, 3H, Me-iPr, J = 8 Hz), 2.16 (s, 3H, Me-Ar), 2.70 (m, 1H, CH-Ar), 5.74 (d, 1H,\nCH (p-cym), J = 8 Hz), 5.925 (d,\n1H, CH (p-cym), J = 4 Hz), 5.98\n(d, 1H, CH (p-cym), J = 8 Hz), 6.03\n(d, 1H, CH (p-cym), J = 8 Hz), 7.45\n(t, 1H, H-8, J = 8 Hz), 7.52 (td, 1H, H-9, J = 8 Hz, J = 1.2 Hz), 7.65 (td, 1H, H-2, J = 8 Hz, J = 2.4 Hz), 7.98 (d, 1H, H-4, J = 8 Hz), 8.02 (t, 1H, H-3, J = 4H), 8.03\n(dd, 1H, H-7, J = 8 Hz, J = 0.8\nHz), 8.37 (d, 1H, H-1, J = 4 Hz), 8.39 (d, 1H, H-10, J = 4 Hz) ppm. 13C NMR (100 MHz, CDCl3): \u03b4 19.2 (Me-Ar), 22.1 (Me-iPr), 22.6 (Me-iPr), 31.2 (CH-iPr), 83.1 (p-cym), 83.4 (p-cym), 83.9 (p-cym),\n88.6 (p-cym), 102.5 (p-cym), 103.7\n(p-cym), 116.9 (L2), 117.7 (L2), 120.2 (L2), 121.7 (L2) 122.9 (L2), 125.8 (L2), 127.4 (L2), 128.1 (L2), 128.2 (L2), 128.9 (L2), 136.2 (L2), 137.9 (L2) 146.3 (L2), 157.0 (L2), 157.6 (L2) ppm. IR: 3083 (w), 3062 (w), 3033 (w), 2971\n(w), 2873 (w), 1692 (s), 1625 (m), 1593 (m), 1561 (m), 1540 (w), 1495\n(s), 1460 (s), 1441 (s), 1404 (m), 1356 (m), 1330 (m), 1316 (m), 1303\n(m), 1242 (s), 1191 (m), 1159 (m), 1146 (m), 1124 (m), 1111 (m), 1095\n(m), 1055 (m), 1039 (m), 1026 (m), 1007 (m), 940 (m), 868 (m), 807\n(s), 794 (m), 759 (s), 743 (s), 727 (m), 709 (m), 687 (s), 674 (m).\nFound, %: C, 56.58; H, 4.22; N, 7.95. C25H22N3O2ClRu. Calcd, %: C, 56.34; H, 4.16; N, 7.88.",
            "cite_spans": [],
            "section": "[Ru(p-cym) (L2)Cl] (2) ::: Synthesis and Characterization ::: NCI Analysis by means of the Reduced Density\nGradient84ref84bibr\u221288ref88bibr was Performed on the Density of the Optimized Structures Using a\nHomemade Code ::: Experimental Section",
            "ref_spans": []
        },
        {
            "text": "HL3 (24.8 mg, 0.1 mmol) was suspended in MeOH\n(5 mL) and 1 mL of 0.1 M solution KOH in MeOH was added. Reaction\nmixture was stirred for 1 h to afford pale yellow precipitate of potassium\nsalt. [Ru(p-cym)Cl2]2 (30.6\nmg, 0.1 mmol) was dissolved in MeOH (2 mL), and solution was added\nto the initial suspension. The resulting red crystals were filtered,\nwashed with MeOH, and dried at room temperature. Yield 47 mg (55%). 1H NMR (400 MHz, CDCl3): \u03b4 1.08 (dd, 6H, Me-iPr (assymm. p-cym), J1 = 24 Hz, J2 = 4 Hz), 1.41\n(dd, 6H, Me-iPr (symm. p-cym), J1 = 16 Hz, J2 =\n8 Hz), 2.20 (s, 3H, Me-Ar (assymm. p-cym)), 2.34\n(s, 3H, Me-Ar (symm. p-cym)), 2.72 (m, 1H, CH-Ar\n(assymm. p-cym)), 3.10 (m, 1H, CH-Ar (symm. p-cym)), 5.30 (d, 1H, CH (symm. p-cym), J = 4 Hz), 5.40 (d, 1H, CH (symm. p-cym), J = 8 Hz), 5.55 (d, 1H, CH (symm. p-cym), J = 4 Hz), 5.58 (d, 1H, CH (symm. p-cym), J = 8 Hz), 5.79 (d, 1H, CH (assymm. p-cym), J = 8 Hz), 5.96 (d, 1H, CH (assymm. p-cym),\n8 Hz), 6.02 (d, 1H, CH (assymm. p-cym), 4 Hz), 6.19\n(d, 1H, CH (assymm. p-cym), 8 Hz), 7.51 (t, 1H, H8-L3, J = 8 Hz), 7.67 (t, 1H, H7-L3, J = 8 Hz),\n8.10 (d, 1H, H4-L3, J = 4 Hz), 8.23 (t, 2H, H9-L3, J = 8 Hz), 9.23 (d, 1H, H3-L3, J = 8 Hz),\n10.10 (s, 1H, H1-L3) ppm. 13C NMR (100 MHz, DMSO-d6): \u03b4 18.3 (Me-Ar), 18.9 (Me-Ar), 22.9\n(Me-iPr), 22.2 (Me-iPr), 22.3 (Me-iPr), 30.4 (CH-iPr) 31.1 (CH-iPr), 83.3 (p-cym), 84.1 (p-cym),\n85.2 (p-cym), 85.9 (p-cym), 86.8\n(p-cym), 90.0 (p-cym), 100.5 (p-cym), 103.3 (p-cym), 103.7 (L3), 106.8 (L3), 121.9 (L3), 123.2 (L3), 124.9 (L3), 128.3 (L3), 132.5 (L3), 134.0 (L3), 144.4 (L3), 146.7 (L3), 146.9 (L3), 148.8 (L3), 151.8 (L3), 157.9 (L3) ppm. IR: 3051 (w), 2955 (m), 2926 (w), 2873\n(w), 1604 (m), 1593 (w), 1561 (w), 1497 (s), 1473 (s), 1412 (s), 1394\n(s), 1359 (m), 1316 (s), 1250 (s), 1204 (m), 1154 (s), 1132 (m), 1116\n(m), 1068 (m), 1028 (m), 978 (m), 874 (m), 826 (s), 802 (s), 773 (s),\n757 (s), 730 (s). Found, %: C, 49.11; H, 4.54; N, 6.43. C35.5H41Cl3N4O2.5Ru2. Calcd, %: C, 48.90; H, 4.74; N, 6.42.",
            "cite_spans": [],
            "section": "[Ru2(p-cym)2(L3)Cl2]\u00b71.5MeOH (3) ::: Synthesis and Characterization ::: NCI Analysis by means of the Reduced Density\nGradient84ref84bibr\u221288ref88bibr was Performed on the Density of the Optimized Structures Using a\nHomemade Code ::: Experimental Section",
            "ref_spans": []
        },
        {
            "text": "HL4 (24.8 mg, 0.1\nmmol) was suspended in DMF (2.5\nmL). [Ru(p-cym)Cl2]2 (30.6\nmg, 0.05 mmol) and was dissolved in MeOH (2.5 mL), and the resulting\nsolution was added to the initial suspension. The mixture was stirred\nuntil the ligand was completely dissolved. The resulting red precipitate\nwas filtered, washed with MeOH, and dried at room temperature. Yield\n42 mg (81%). 1H NMR (400 MHz, DMSO-d6): \u03b4 1.005 (d, 3H, Me-iPr, J = 4 Hz), 1.075 (d, 3H, Me-iPr, J = 4 Hz), 2.15 (s, 3H, Me-Ar), 2.68 (m, 1H, CH-Ar), 5.805\n(d, 1H, CH (p-cym), J = 4 Hz), 6.03\n(d, 1H, CH (p-cym), J = 8 Hz), 6.045\n(d, 1H, CH (p-cym), J = 4 Hz), 6.105\n(d, 1H, CH (p-cym), J = 4 Hz), 7.57\n(t, 1H, H8-L3, J = 8 Hz), 7.70 (t, 1H,\nH3-L3, J = 8 Hz), 8.015 (dd, 1H, H9-L3, J = 12 Hz, J = 4 Hz),\n8.09 (d, 1H, H7-L3, J = 8 Hz), 8.26 (d,\n1H, H10-L3, J = 8 Hz), 8.795 (dd, 1H,\nH4-L3, J = 10 Hz, J =\n1.6 Hz), 9.195 (dd, 1H, H2-L3, J = 4 Hz, J = 1.6 Hz) ppm. 13C NMR (100 MHz, CDCl3): \u03b4 21.9 (Me-Ar), 24.1 (Me-iPr), 30.9 (Me-iPr), 31.2 (CH-iPr), 83.6 (p-cym), 83.9 (p-cym), 85.9 (p-cym),\n87.0 (p-cym), 89.3 (p-cym), 100.6\n(p-cym), 122.8 (L4), 124.2 (L4), 124.6 (L4), 124.6 (L4) 126.0 (L4), 126.2 (L4), 127.3 (L4), 128.9 (L4), 132.9 (L4), 133.9 (L4), 136.3 (L4), 138.7 (L4), 139.7 (L4), 156.4 (L4) ppm. IR: 3056 (w), 2971 (w), 2923 (w), 2873 (w), 1679 (s), 1620\n(m), 1604 (m), 1569 (m), 1511 (m), 1495 (s), 1476 (s), 1460 (s), 1417\n(s), 1380 (m), 1359 (m), 1308 (s), 1282 (m), 1242 (s), 1204 (m), 1175\n(m), 1154 (m), 1149 (m), 1111 (m), 1076 (m), 1036 (m), 1007 (m), 996\n(m), 959 (m), 911 (m), 890 (m), 876 (m), 820 (m), 797 (m), 775 (s),\n762 (s), 738 (m), 690 (m). Found, %: C, 55.03; H, 4.48; N, 11.53.\nC25.5H24.5ClN4.5O1.5Ru.\nCalcd, %: C, 55.23; H, 4.45; N, 11.37.",
            "cite_spans": [],
            "section": "[Ru(p-cym)2(L4)Cl2]\u00b70.5DMF (4) ::: Synthesis and Characterization ::: NCI Analysis by means of the Reduced Density\nGradient84ref84bibr\u221288ref88bibr was Performed on the Density of the Optimized Structures Using a\nHomemade Code ::: Experimental Section",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Figure 1: X-ray molecular structure\nof complex 1. Thermal ellipsoids\nare drawn at a 50% probability level. Hydrogen atoms are omitted for\nclarity. Selected bond lengths [\u00c5]: Ru1\u2013N1 2.101(1), Ru1\u2013N2\n2.147(1), Ru1\u2013Cl1 2.4066(5), Ru1\u2013C16 2.193(2), Ru1\u2013C17\n2.175(2), Ru1\u2013C18 2.256(2), Ru1\u2013C19 2.264(2), Ru1\u2013C20\n2.186(2), Ru1\u2013C21 2.181(2).",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: X-ray\nmolecular structure of complex 2. Thermal ellipsoids\nare drawn at a 50% probability level. Hydrogen atoms are omitted for\nclarity. Selected bond lengths [\u00c5]: Ru1\u2013N1 2.079(1), Ru1\u2013N2\n2.159(1), Ru1\u2013Cl1 2.4041(7), Ru1\u2013C16 2.200(1), Ru1\u2013C17\n2.177(2), Ru1\u2013C18 2.255(1), Ru1\u2013C19 2.265(2), Ru1\u2013C20\n2.183(2), Ru1\u2013C21 2.180(2).",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure 3: X-ray\nmolecular structure of complex 4. Thermal ellipsoids\nare drawn at a 50% probability level. Hydrogen atoms and DMF solvent\nmolecules are omitted for clarity. Selected bond lengths [\u00c5]:\nRu1\u2013N1 2.094(2), Ru1\u2013N2 2.124(2), Ru1\u2013Cl1 2.4031(6),\nRu1\u2013C15 2.212(2), Ru1\u2013C16 2.172(2), Ru1\u2013C17 2.189(2),\nRu1\u2013C18 2.260(2), Ru1\u2013C19 2.249(2), Ru1\u2013C20 2.171(2).",
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Figure 4: X-ray molecular structure of 3. Thermal ellipsoids\nare drawn at a 50% probability level. Hydrogen atoms and MeOH solvent\nmolecules are omitted for clarity. Selected bond lengths [\u00c5]:\nRu1\u2013N1 2.096(2), Ru1\u2013N2 2.124(2), Ru1\u2013Cl1 2.387(2),\nRu1\u2013C15 2.207(5), Ru1\u2013C16 2.146(6), Ru1\u2013C17 2.182(4),\nRu1\u2013C18 2.238(3), Ru1\u2013C19 2.230(3), Ru1\u2013C20 2.189(4),\nRu1\u2013N4 2.134(2), Ru1\u2013Cl2 2.425(1), Ru1\u2013Cl3 2.412(1),\nRu1\u2013C25 2.203(4), Ru1\u2013C26 2.179(5), Ru1\u2013C27 2.153(5),\nRu1\u2013C28 2.187(5), Ru1\u2013C29 2.169(4), Ru1\u2013C30 2.183(3).",
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Figure 5: Conversion versus reaction\ntime for acetophenone transfer hydrogenation.",
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Figure 6: Conversion\nversus time plots (entries 2\u20136 in Table 4).",
            "type": "figure"
        },
        "FIGREF6": {
            "text": "Figure 7: Cell viability\nMTT assay results for complexes 1\u20134 against PANC-1\n(top) and ARPE-19 (bottom) cell lines (values are\nshown as the mean \u00b1 SEM of four experiments, the concentrations\nof the complexes on the horizontal axis are given in \u03bcM).",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Synthesis, X-Ray Structure,\nin Vitro HIV and Kinesin Eg5 Inhibition Activities of New Arene Ruthenium\nComplexes of Pyrimidine Analogs",
            "authors": [],
            "year": 2017,
            "venue": "J. Coord. Chem.",
            "volume": "70",
            "issn": "",
            "pages": "2061-2073",
            "other_ids": {
                "DOI": [
                    "10.1080/00958972.2017.1334259"
                ]
            }
        },
        "BIBREF1": {
            "title": "Advances in the Design of Organometallic\nAnticancer\nComplexes",
            "authors": [],
            "year": 2017,
            "venue": "J. Organomet. Chem.",
            "volume": "839",
            "issn": "",
            "pages": "5-14",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jorganchem.2017.03.038"
                ]
            }
        },
        "BIBREF2": {
            "title": "[Ru(\u03976-p-Cymene)Cl2(Pta)]\n(Pta = 1,3,5-Triaza-7-Phosphatricyclo[3.3.1.1]Decane): A Water Soluble\nCompound That Exhibits PH Dependent DNA Binding Providing Selectivity\nfor Diseased Cells",
            "authors": [],
            "year": 2001,
            "venue": "Chem. Commun.",
            "volume": "15",
            "issn": "",
            "pages": "1396-1397",
            "other_ids": {
                "DOI": [
                    "10.1039/b104021a"
                ]
            }
        },
        "BIBREF3": {
            "title": "In Vivo Anti-Tumor Activity of the Organometallic Ruthenium(\nIi )-Arene Complex [Ru(\u03b7 6 - p -Cymene)Cl 2 (Pta)] (RAPTA-C) in Human Ovarian and Colorectal Carcinomas",
            "authors": [],
            "year": 2014,
            "venue": "Chem. Sci.",
            "volume": "5",
            "issn": "",
            "pages": "4742-4748",
            "other_ids": {
                "DOI": [
                    "10.1039/C4SC01255K"
                ]
            }
        },
        "BIBREF4": {
            "title": "Non-Platinum Group\nMetal Antitumor Agents. History, Current Status,\nand Perspectives",
            "authors": [],
            "year": 1987,
            "venue": "Chem. Rev.",
            "volume": "87",
            "issn": "",
            "pages": "1137-1152",
            "other_ids": {
                "DOI": [
                    "10.1021/cr00081a012"
                ]
            }
        },
        "BIBREF5": {
            "title": "Anti-Tumour Activity in Non-Small Cell Lung Cancer\nModels and Toxicity Profiles for Novel Ruthenium(II) Based Organo-Metallic\nCompounds",
            "authors": [],
            "year": 2006,
            "venue": "Biochem. Pharmacol.",
            "volume": "71",
            "issn": "",
            "pages": "408-415",
            "other_ids": {
                "DOI": [
                    "10.1016/J.BCP.2005.10.053"
                ]
            }
        },
        "BIBREF6": {
            "title": "In Vitro\nand in\nVivo Activity and Cross Resistance Profiles of Novel Ruthenium (II)\nOrganometallic Arene Complexes in Human Ovarian Cancer",
            "authors": [],
            "year": 2002,
            "venue": "Br. J. Cancer",
            "volume": "86",
            "issn": "",
            "pages": "1652-1657",
            "other_ids": {
                "DOI": [
                    "10.1038/sj.bjc.6600290"
                ]
            }
        },
        "BIBREF7": {
            "title": "Inhibition of Cancer Cell Growth\nby Ruthenium(II) Arene Complexes",
            "authors": [],
            "year": 2001,
            "venue": "J. Med. Chem.",
            "volume": "44",
            "issn": "",
            "pages": "3616-3621",
            "other_ids": {
                "DOI": [
                    "10.1021/jm010051m"
                ]
            }
        },
        "BIBREF8": {
            "title": "Synthesis, Characterization and Cytotoxicity\nof Arene\u2013Ruthenium(Ii) Complexes with Acylpyrazolones Functionalized\nwith Aromatic Groups in the Acyl Moiety",
            "authors": [],
            "year": 2018,
            "venue": "Dalton\nTrans.",
            "volume": "47",
            "issn": "",
            "pages": "868-878",
            "other_ids": {
                "DOI": [
                    "10.1039/C7DT04249C"
                ]
            }
        },
        "BIBREF9": {
            "title": "The Hydrogenation/Transfer\nHydrogenation Network: Asymmetric\nHydrogenation of Ketones with Chiral \u03976 -Arene/ N -Tosylethylenediamine\u2013Ruthenium(II)\nCatalysts",
            "authors": [],
            "year": 2006,
            "venue": "J. Am. Chem. Soc.",
            "volume": "128",
            "issn": "",
            "pages": "8724-8725",
            "other_ids": {
                "DOI": [
                    "10.1021/ja0620989"
                ]
            }
        },
        "BIBREF10": {
            "title": "Relating Catalytic\nActivity and Electrochemical Properties: The Case of Arene\u2013Ruthenium\nPhenanthroline Complexes Catalytically Active in Transfer Hydrogenation",
            "authors": [],
            "year": 2006,
            "venue": "Inorg. Chim. Acta",
            "volume": "359",
            "issn": "",
            "pages": "2369-2374",
            "other_ids": {
                "DOI": [
                    "10.1016/j.ica.2006.02.037"
                ]
            }
        },
        "BIBREF11": {
            "title": "Ruthenium Arene Complexes\nas HIV-1 Integrase Strand Transfer Inhibitors",
            "authors": [],
            "year": 2013,
            "venue": "J. Inorg. Biochem.",
            "volume": "118",
            "issn": "",
            "pages": "74-82",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jinorgbio.2012.09.021"
                ]
            }
        },
        "BIBREF12": {
            "title": "The First Examples of Discotic Liquid Crystalline Gemini\nSurfactants",
            "authors": [],
            "year": 2010,
            "venue": "Tetrahedron Lett.",
            "volume": "51",
            "issn": "",
            "pages": "5459-5462",
            "other_ids": {
                "DOI": [
                    "10.1016/j.tetlet.2010.08.022"
                ]
            }
        },
        "BIBREF13": {
            "title": "Synthesis and Characterization\nof Ru(Arene) Complexes of Bispyrazolylazines: Catalytic Hydrogen Transfer\nof Ketones",
            "authors": [],
            "year": 2009,
            "venue": "Inorg. Chim. Acta",
            "volume": "362",
            "issn": "",
            "pages": "4486-4492",
            "other_ids": {
                "DOI": [
                    "10.1016/j.ica.2009.04.011"
                ]
            }
        },
        "BIBREF14": {
            "title": "Ruthenium Arene Complexes with \u03b1-Aminoacidato\nLigands: New Insights into Transfer Hydrogenation Reactions and Cytotoxic\nBehaviour",
            "authors": [],
            "year": 2018,
            "venue": "Eur. J. Inorg. Chem.",
            "volume": "2018",
            "issn": "",
            "pages": "3041-3057",
            "other_ids": {
                "DOI": [
                    "10.1002/ejic.201800284"
                ]
            }
        },
        "BIBREF15": {
            "title": "Hydrogenation versus Transfer Hydrogenation of Ketones:\nTwo Established Ruthenium Systems Catalyze Both",
            "authors": [],
            "year": 2003,
            "venue": "Chem.\u2014Eur. J.",
            "volume": "9",
            "issn": "",
            "pages": "4954-4967",
            "other_ids": {
                "DOI": [
                    "10.1002/chem.200304884"
                ]
            }
        },
        "BIBREF16": {
            "title": "Selective Hydrogenation\nfor Fine Chemicals: Recent\nTrends and New Developments",
            "authors": [],
            "year": 2003,
            "venue": "Adv. Synth. Catal.",
            "volume": "345",
            "issn": "",
            "pages": "103-151",
            "other_ids": {
                "DOI": [
                    "10.1002/adsc.200390000"
                ]
            }
        },
        "BIBREF17": {
            "title": "Mechanisms of the\nH2-Hydrogenation\nand Transfer Hydrogenation of Polar Bonds Catalyzed by Ruthenium Hydride\nComplexes",
            "authors": [],
            "year": 2004,
            "venue": "Coord. Chem. Rev.",
            "volume": "248",
            "issn": "",
            "pages": "2201-2237",
            "other_ids": {
                "DOI": [
                    "10.1016/J.CCR.2004.04.007"
                ]
            }
        },
        "BIBREF18": {
            "title": "Synthesis, Reactivity,\nand Catalytic\nTransfer Hydrogenation Activity of Ruthenium Complexes Bearing NNN\nTridentate Ligands: Influence of the Secondary Coordination Sphere",
            "authors": [],
            "year": 2017,
            "venue": "ACS Omega",
            "volume": "2",
            "issn": "",
            "pages": "3406-3416",
            "other_ids": {
                "DOI": [
                    "10.1021/acsomega.7b00410"
                ]
            }
        },
        "BIBREF19": {
            "title": "Preparation and\nStudy of Reusable Polymerized Catalysts for Ester Hydrogenation",
            "authors": [],
            "year": 2019,
            "venue": "ACS Omega",
            "volume": "4",
            "issn": "",
            "pages": "12212-12221",
            "other_ids": {
                "DOI": [
                    "10.1021/acsomega.9b01682"
                ]
            }
        },
        "BIBREF20": {
            "title": "Allenylidene-Ruthenium-Arene\nPrecatalyst for Ring Opening\nMetathesis Polymerisation (ROMP)",
            "authors": [],
            "year": 2002,
            "venue": "J. Organomet.\nChem.",
            "volume": "663",
            "issn": "",
            "pages": "235-238",
            "other_ids": {
                "DOI": [
                    "10.1016/S0022-328X(02)01880-6"
                ]
            }
        },
        "BIBREF21": {
            "title": "Highly Active Catalysts\nin Alkene Metathesis: First\nObserved Transformation of Allenylidene into Indenylidene via Alkenylcarbyne\u2014Ruthenium\nSpecies",
            "authors": [],
            "year": 2003,
            "venue": "Angew. Chem., Int. Ed.",
            "volume": "42",
            "issn": "",
            "pages": "4524-4527",
            "other_ids": {
                "DOI": [
                    "10.1002/anie.200352108"
                ]
            }
        },
        "BIBREF22": {
            "title": "Synthesis\nand Characterisation of Some Water Soluble Ruthenium(II)-Arene Complexes\nand an Investigation of Their Antibiotic and Antiviral Properties",
            "authors": [],
            "year": 2003,
            "venue": "J. Organomet. Chem.",
            "volume": "668",
            "issn": "",
            "pages": "35-42",
            "other_ids": {
                "DOI": [
                    "10.1016/S0022-328X(02)01926-5"
                ]
            }
        },
        "BIBREF23": {
            "title": "Allenylidene-to-Indenylidene\nRearrangement in Arene\u2013Ruthenium Complexes: A Key Step to Highly\nActive Catalysts for Olefin Metathesis Reactions",
            "authors": [],
            "year": 2006,
            "venue": "J. Am. Chem. Soc.",
            "volume": "128",
            "issn": "",
            "pages": "4079-4089",
            "other_ids": {
                "DOI": [
                    "10.1021/ja0579762"
                ]
            }
        },
        "BIBREF24": {
            "title": "Synthesis, Biological\nEvaluation, and Molecular Modeling\nof 11H-Indeno[1,2-b]Quinoxalin-11-One Derivatives and Tryptanthrin-6-Oxime\nas c-Jun N-Terminal Kinase Inhibitors",
            "authors": [],
            "year": 2019,
            "venue": "Eur.\nJ. Med. Chem.",
            "volume": "161",
            "issn": "",
            "pages": "179-191",
            "other_ids": {
                "DOI": [
                    "10.1016/J.EJMECH.2018.10.023"
                ]
            }
        },
        "BIBREF25": {
            "title": "Identification and\nCharacterization of a Novel Class of C-Jun N-Terminal Kinase Inhibitors",
            "authors": [],
            "year": 2012,
            "venue": "Mol. Pharmacol.",
            "volume": "81",
            "issn": "",
            "pages": "832-845",
            "other_ids": {
                "DOI": [
                    "10.1124/mol.111.077446"
                ]
            }
        },
        "BIBREF26": {
            "title": "Anti-Inflammatory\nEffects and Joint Protection in Collagen-Induced\nArthritis after Treatment with IQ-1S, a Selective c-Jun N-Terminal\nKinase Inhibitor",
            "authors": [],
            "year": 2015,
            "venue": "J. Pharmacol. Exp. Ther.",
            "volume": "353",
            "issn": "",
            "pages": "505-516",
            "other_ids": {
                "DOI": [
                    "10.1124/jpet.114.220251"
                ]
            }
        },
        "BIBREF27": {
            "title": "Poly(\u03b5-Caprolactone) Scaffolds\nDoped with c-Jun\nN-Terminal Kinase Inhibitors Modulate Phagocyte Activation",
            "authors": [],
            "year": 2019,
            "venue": "ACS Biomater. Sci. Eng.",
            "volume": "5",
            "issn": "",
            "pages": "5990-5999",
            "other_ids": {
                "DOI": [
                    "10.1021/acsbiomaterials.9b01401"
                ]
            }
        },
        "BIBREF28": {
            "title": "Electrosprayed\nPoly(Lactic-Co-Glycolic Acid) Particles as a Promising Drug Delivery\nSystem for the Novel JNK Inhibitor IQ-1",
            "authors": [],
            "year": 2020,
            "venue": "Eur.\nPolym. J.",
            "volume": "127",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.eurpolymj.2020.109598"
                ]
            }
        },
        "BIBREF29": {
            "title": "A Novel Dual NO-Donating\nOxime and c-Jun N-Terminal Kinase Inhibitor Protects against Cerebral\nIschemia\u2013Reperfusion Injury in Mice",
            "authors": [],
            "year": 2016,
            "venue": "Neurosci. Lett.",
            "volume": "618",
            "issn": "",
            "pages": "45-49",
            "other_ids": {
                "DOI": [
                    "10.1016/j.neulet.2016.02.033"
                ]
            }
        },
        "BIBREF30": {
            "title": "Protective Effects\nof a New C-Jun N-Terminal Kinase\nInhibitor in the Model of Global Cerebral Ischemia in Rats",
            "authors": [],
            "year": 2019,
            "venue": "Molecules",
            "volume": "24",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.3390/molecules24091722"
                ]
            }
        },
        "BIBREF31": {
            "title": "Design, Synthesis and\nAntitumor Activity of Non-Camptothecin Topoisomerase\nI Inhibitors",
            "authors": [],
            "year": 2015,
            "venue": "Bioorg. Med. Chem. Lett.",
            "volume": "25",
            "issn": "",
            "pages": "4693-4696",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bmcl.2015.06.042"
                ]
            }
        },
        "BIBREF32": {
            "title": "Discovery of Indeno[1,2-b]Quinoxaline\nDerivatives as Potential Anticancer Agents",
            "authors": [],
            "year": 2016,
            "venue": "Eur. J. Med. Chem.",
            "volume": "108",
            "issn": "",
            "pages": "258-273",
            "other_ids": {
                "DOI": [
                    "10.1016/j.ejmech.2015.11.031"
                ]
            }
        },
        "BIBREF33": {
            "title": "New Strategy for Reversing\nBiofilm-Associated Antibiotic Resistance\nthrough Ferrocene-Substituted Carborane Ruthenium(II)-Arene Complex",
            "authors": [],
            "year": 2013,
            "venue": "Sci. China: Chem.",
            "volume": "56",
            "issn": "",
            "pages": "595-603",
            "other_ids": {
                "DOI": [
                    "10.1007/s11426-012-4812-6"
                ]
            }
        },
        "BIBREF34": {
            "title": "Discovery\nof Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1)\nas Effective Intracellular ROS Generators for the Treatment of Drug-Resistant\nNon-Small-Cell Lung Cancer",
            "authors": [],
            "year": 2018,
            "venue": "J. Med. Chem.",
            "volume": "61",
            "issn": "",
            "pages": "11280-11297",
            "other_ids": {
                "DOI": [
                    "10.1021/acs.jmedchem.8b01424"
                ]
            }
        },
        "BIBREF35": {
            "title": "Recent Synthetic and\nMedicinal Perspectives of Tryptanthrin",
            "authors": [],
            "year": 2017,
            "venue": "Bioorg.\nMed. Chem.",
            "volume": "25",
            "issn": "",
            "pages": "4533-4552",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bmc.2017.07.003"
                ]
            }
        },
        "BIBREF36": {
            "title": "Tryptanthrin\nPrevents Oxidative Stress-Mediated\nApoptosis through AMP-Activated Protein Kinase-Dependent P38 Mitogen-Activated\nProtein Kinase Activation",
            "authors": [],
            "year": 2017,
            "venue": "Arch. Pharmacal Res.",
            "volume": "40",
            "issn": "",
            "pages": "1071-1086",
            "other_ids": {
                "DOI": [
                    "10.1007/s12272-017-0947-5"
                ]
            }
        },
        "BIBREF37": {
            "title": "Inhibition\nof Toxoplasma Gondii</Em> by Indirubin and Tryptanthrin Analogs",
            "authors": [],
            "year": 2008,
            "venue": "Antimicrob. Agents Chemother.",
            "volume": "52",
            "issn": "",
            "pages": "4466-4469",
            "other_ids": {
                "DOI": [
                    "10.1128/AAC.00903-08"
                ]
            }
        },
        "BIBREF38": {
            "title": "Design, Synthesis, and Structure\u2013Activity\nRelationship Studies of Tryptanthrins As Antitubercular Agents",
            "authors": [],
            "year": 2013,
            "venue": "J. Nat. Prod.",
            "volume": "76",
            "issn": "",
            "pages": "354-367",
            "other_ids": {
                "DOI": [
                    "10.1021/np3007167"
                ]
            }
        },
        "BIBREF39": {
            "title": "Antiviral Action\nof Tryptanthrin Isolated from Strobilanthes Cusia Leaf against Human\nCoronavirus NL63",
            "authors": [],
            "year": 2020,
            "venue": "Biomolecules",
            "volume": "10",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.3390/biom10030366"
                ]
            }
        },
        "BIBREF40": {
            "title": "Pre-clinical evidences\nfor the efficacy of tryptanthrin as a potent suppressor of skin cancer",
            "authors": [],
            "year": 2020,
            "venue": "Cell Proliferation",
            "volume": "53",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1111/cpr.12710"
                ]
            }
        },
        "BIBREF41": {
            "title": "A Biomimetic,\nOne-Step Transformation\nof Simple Indolic Compounds to Malassezia-Related Alkaloids with High\nAhR Potency and Efficacy",
            "authors": [],
            "year": 2019,
            "venue": "Chem. Res. Toxicol.",
            "volume": "32",
            "issn": "",
            "pages": "2238-2249",
            "other_ids": {
                "DOI": [
                    "10.1021/acs.chemrestox.9b00270"
                ]
            }
        },
        "BIBREF42": {
            "title": "Anti-inflammatory\neffect of alkaloids\nextracted from Dendrobium aphyllum on macrophage RAW 264.7 cells through\nNO production and reduced IL-1, IL-6, TNF-\u03b1 and PGE2 expression",
            "authors": [],
            "year": 2020,
            "venue": "Int. J. Food Sci. Technol.",
            "volume": "55",
            "issn": "",
            "pages": "1255-1264",
            "other_ids": {
                "DOI": [
                    "10.1111/ijfs.14404"
                ]
            }
        },
        "BIBREF43": {
            "title": "A Family of Polynuclear Cobalt Complexes upon Employment\nof an Indeno-Quinoxaline Based Oxime Ligand",
            "authors": [],
            "year": 2014,
            "venue": "RSC Adv.",
            "volume": "4",
            "issn": "",
            "pages": "23068-23077",
            "other_ids": {
                "DOI": [
                    "10.1039/C4RA01914H"
                ]
            }
        },
        "BIBREF44": {
            "title": "Bioactive\nRuthenium(II)-Arene Complexes Containing Modified 18\u03b2-Glycyrrhetinic\nAcid Ligands",
            "authors": [],
            "year": 2018,
            "venue": "J. Inorg. Biochem.",
            "volume": "182",
            "issn": "",
            "pages": "194-199",
            "other_ids": {
                "DOI": [
                    "10.1016/J.JINORGBIO.2018.02.004"
                ]
            }
        },
        "BIBREF45": {
            "title": "An Indeno-Quinoxaline\nBased Oxime Ligand for the Synthesis of Polynuclear Ni(Ii) Clusters",
            "authors": [],
            "year": 2013,
            "venue": "RSC Adv.",
            "volume": "3",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1039/c3ra41455h"
                ]
            }
        },
        "BIBREF46": {
            "title": "Neutral\nand Cationic Half-Sandwich Arene Ruthenium, Cp*Rh and Cp*Ir Oximato\nand Oxime Complexes: Synthesis, Structural, DFT and Biological Studies",
            "authors": [],
            "year": 2016,
            "venue": "J. Organomet. Chem.",
            "volume": "820",
            "issn": "",
            "pages": "70-81",
            "other_ids": {
                "DOI": [
                    "10.1016/J.JORGANCHEM.2016.08.004"
                ]
            }
        },
        "BIBREF47": {
            "title": "Half-Sandwich\nRuthenium, Rhodium and Iridium Complexes Featuring Oxime Ligands:\nStructural Studies and Preliminary Investigation of in Vitro and in Vivo Anti-Tumour Activities",
            "authors": [],
            "year": 2017,
            "venue": "Appl. Organomet. Chem.",
            "volume": "31",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/aoc.3640"
                ]
            }
        },
        "BIBREF48": {
            "title": "Biological Evaluation of Water Soluble\nArene Ru(II) Enantiomers with Amino-Oxime Ligands",
            "authors": [],
            "year": 2018,
            "venue": "J. Inorg. Biochem.",
            "volume": "183",
            "issn": "",
            "pages": "32-42",
            "other_ids": {
                "DOI": [
                    "10.1016/J.JINORGBIO.2018.02.018"
                ]
            }
        },
        "BIBREF49": {
            "title": "Study of\nthe Bonding Modes of Di-2-Pyridyl\nKetoxime Ligand towards Ruthenium, Rhodium and Iridium Half Sandwich\nComplexes",
            "authors": [],
            "year": 2016,
            "venue": "Z. Anorg. Allg. Chem.",
            "volume": "642",
            "issn": "",
            "pages": "941-946",
            "other_ids": {
                "DOI": [
                    "10.1002/zaac.201600260"
                ]
            }
        },
        "BIBREF50": {
            "title": "Use of\nChelating Ligands to Tune the Reactive Site of Half-Sandwich Ruthenium(II)\u2013Arene\nAnticancer Complexes",
            "authors": [],
            "year": 2004,
            "venue": "Chem.\u2014Eur. J.",
            "volume": "10",
            "issn": "",
            "pages": "5173-5179",
            "other_ids": {
                "DOI": [
                    "10.1002/chem.200400640"
                ]
            }
        },
        "BIBREF51": {
            "title": "Osmium(II) and Ruthenium(II) Arene\nMaltolato Complexes: Rapid Hydrolysis and Nucleobase Binding",
            "authors": [],
            "year": 2007,
            "venue": "Chem.\u2014Eur. J.",
            "volume": "13",
            "issn": "",
            "pages": "2601-2613",
            "other_ids": {
                "DOI": [
                    "10.1002/chem.200601152"
                ]
            }
        },
        "BIBREF52": {
            "title": "Tunable Single-Site\nRuthenium Catalysts for Efficient Water Oxidation",
            "authors": [],
            "year": 2011,
            "venue": "Chem. Commun.",
            "volume": "47",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1039/c1cc12615f"
                ]
            }
        },
        "BIBREF53": {
            "title": "Synthesis, Characterisation, and\nProperties of p-Cymene\nRuthenium(II) Tetracarboxylate Bipyridine Complexes [(\u03976-p-Cymene)Ru(Rn,Rn\u2032-Tcbpy)Cl][Cl]",
            "authors": [],
            "year": 2016,
            "venue": "J. Organomet. Chem.",
            "volume": "823",
            "issn": "",
            "pages": "136-146",
            "other_ids": {
                "DOI": [
                    "10.1016/J.JORGANCHEM.2016.08.030"
                ]
            }
        },
        "BIBREF54": {
            "title": "Synergistic\nActivity of Hsp90 Inhibitors\nand Anticancer Agents in Pancreatic Cancer Cell Cultures",
            "authors": [],
            "year": 2019,
            "venue": "Sci. Rep.",
            "volume": "9",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/s41598-019-52652-1"
                ]
            }
        },
        "BIBREF55": {
            "title": "A Novel Dual-Functioning\nRuthenium(II)\u2013Arene Complex of an Anti-Microbial Ciprofloxacin\nDerivative \u2014 Anti-Proliferative and Anti-Microbial Activity",
            "authors": [],
            "year": 2016,
            "venue": "J. Inorg. Biochem.",
            "volume": "160",
            "issn": "",
            "pages": "210-217",
            "other_ids": {
                "DOI": [
                    "10.1016/J.JINORGBIO.2016.02.018"
                ]
            }
        },
        "BIBREF56": {
            "title": "Predicting the Chemosensitivity\nof Pancreatic Cancer\nCells by Quantifying the Expression Levels of Genes Associated with\nthe Metabolism of Gemcitabine and 5-Fluorouracil",
            "authors": [],
            "year": 2011,
            "venue": "Int. J. Oncol.",
            "volume": "39",
            "issn": "",
            "pages": "473-482",
            "other_ids": {
                "DOI": [
                    "10.3892/ijo.2011.1058"
                ]
            }
        },
        "BIBREF57": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF58": {
            "title": "SHELXT\n- Integrated Space-Group and Crystal-Structure Determination",
            "authors": [],
            "year": 2015,
            "venue": "Acta Crystallogr., Sect. A: Found. Crystallogr.",
            "volume": "71",
            "issn": "",
            "pages": "3-8",
            "other_ids": {
                "DOI": [
                    "10.1107/S2053273314026370"
                ]
            }
        },
        "BIBREF59": {
            "title": "Crystal Structure\nRefinement with SHELXL",
            "authors": [],
            "year": 2015,
            "venue": "Acta\nCrystallogr., Sect. C: Struct. Chem.",
            "volume": "71",
            "issn": "",
            "pages": "3-8",
            "other_ids": {
                "DOI": [
                    "10.1107/S2053229614024218"
                ]
            }
        },
        "BIBREF60": {
            "title": "OLEX2\u202f: A Complete Structure Solution, Refinement and Analysis\nProgram",
            "authors": [],
            "year": 2009,
            "venue": "J. Appl. Crystallogr.",
            "volume": "42",
            "issn": "",
            "pages": "339-341",
            "other_ids": {
                "DOI": [
                    "10.1107/S0021889808042726"
                ]
            }
        },
        "BIBREF61": {
            "title": "Self-Assembled\nSpin-Labeled Nanoparticles Based on Poly(Amino Acids)",
            "authors": [],
            "year": 2016,
            "venue": "React. Funct. Polym.",
            "volume": "100",
            "issn": "",
            "pages": "173-180",
            "other_ids": {
                "DOI": [
                    "10.1016/J.REACTFUNCTPOLYM.2016.01.018"
                ]
            }
        },
        "BIBREF62": {
            "title": "",
            "authors": [],
            "year": 2013,
            "venue": "Gaussian 09, Revision D.01",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF63": {
            "title": "Density-Functional\nExchange-Energy Approximation with Correct Asymptotic Behavior",
            "authors": [],
            "year": 1988,
            "venue": "Phys. Rev. A: At., Mol., Opt. Phys.",
            "volume": "38",
            "issn": "",
            "pages": "3098-3100",
            "other_ids": {
                "DOI": [
                    "10.1103/physreva.38.3098"
                ]
            }
        },
        "BIBREF64": {
            "title": "Development of the Colle-Salvetti\nCorrelation-Energy Formula into a Functional of the Electron Density",
            "authors": [],
            "year": 1988,
            "venue": "Phys. Rev. B: Condens. Matter Mater. Phys.",
            "volume": "37",
            "issn": "",
            "pages": "785-789",
            "other_ids": {
                "DOI": [
                    "10.1103/PhysRevB.37.785"
                ]
            }
        },
        "BIBREF65": {
            "title": "Accurate Spin-Dependent Electron\nLiquid Correlation Energies for Local Spin Density Calculations: A\nCritical Analysis",
            "authors": [],
            "year": 1980,
            "venue": "Can. J. Phys.",
            "volume": "58",
            "issn": "",
            "pages": "1200-1211",
            "other_ids": {
                "DOI": [
                    "10.1139/p80-159"
                ]
            }
        },
        "BIBREF66": {
            "title": "The Development\nof RAPTA Compounds for the Treatment of Tumors",
            "authors": [],
            "year": 2016,
            "venue": "Coordination Chemistry Reviews",
            "volume": "",
            "issn": "",
            "pages": "86-114",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF67": {
            "title": "Ab Initio Calculation\nof Vibrational Absorption and Circular Dichroism Spectra Using Density\nFunctional Force Fields",
            "authors": [],
            "year": 1994,
            "venue": "J. Phys. Chem.",
            "volume": "98",
            "issn": "",
            "pages": "11623-11627",
            "other_ids": {
                "DOI": [
                    "10.1021/j100096a001"
                ]
            }
        },
        "BIBREF68": {
            "title": "Contracted Gaussian Basis Sets for\nMolecular Calculations.\nI. Second Row Atoms, Z =11\u201318",
            "authors": [],
            "year": 1980,
            "venue": "J. Chem. Phys.",
            "volume": "72",
            "issn": "",
            "pages": "5639-5648",
            "other_ids": {
                "DOI": [
                    "10.1063/1.438980"
                ]
            }
        },
        "BIBREF69": {
            "title": "Self-consistent\nMolecular Orbital Methods. XX. A Basis Set for Correlated Wave Functions",
            "authors": [],
            "year": 1980,
            "venue": "J. Chem. Phys.",
            "volume": "72",
            "issn": "",
            "pages": "650-654",
            "other_ids": {
                "DOI": [
                    "10.1063/1.438955"
                ]
            }
        },
        "BIBREF70": {
            "title": "Efficient Diffuse\nFunction-augmented Basis Sets for Anion Calculations. III. The 3-21+G\nBasis Set for First-row Elements, Li\u2013F",
            "authors": [],
            "year": 1983,
            "venue": "J. Comput. Chem.",
            "volume": "4",
            "issn": "",
            "pages": "294-301",
            "other_ids": {
                "DOI": [
                    "10.1002/jcc.540040303"
                ]
            }
        },
        "BIBREF71": {
            "title": "Self-consistent\nMolecular Orbital\nMethods 25. Supplementary Functions for Gaussian Basis Sets",
            "authors": [],
            "year": 1984,
            "venue": "J. Chem. Phys.",
            "volume": "80",
            "issn": "",
            "pages": "3265-3269",
            "other_ids": {
                "DOI": [
                    "10.1063/1.447079"
                ]
            }
        },
        "BIBREF72": {
            "title": "Ab Initio Effective Core Potentials\nfor Molecular Calculations. Potentials for K to Au Including the Outermost\nCore Orbitals",
            "authors": [],
            "year": 1985,
            "venue": "J. Chem. Phys.",
            "volume": "82",
            "issn": "",
            "pages": "299-310",
            "other_ids": {
                "DOI": [
                    "10.1063/1.448975"
                ]
            }
        },
        "BIBREF73": {
            "title": "Ab Initio Effective Core Potentials\nfor Molecular Calculations. Potentials for the Transition Metal Atoms\nSc to Hg",
            "authors": [],
            "year": 1985,
            "venue": "J. Chem. Phys.",
            "volume": "82",
            "issn": "",
            "pages": "270-283",
            "other_ids": {
                "DOI": [
                    "10.1063/1.448799"
                ]
            }
        },
        "BIBREF74": {
            "title": "The IEF Version of the PCM Solvation\nMethod: An Overview of a New Method Addressed to Study Molecular Solutes\nat the QM Ab Initio Level",
            "authors": [],
            "year": 1999,
            "venue": "J. Mol. Struct.:\nTHEOCHEM",
            "volume": "464",
            "issn": "",
            "pages": "211-226",
            "other_ids": {
                "DOI": [
                    "10.1016/S0166-1280(98)00553-3"
                ]
            }
        },
        "BIBREF75": {
            "title": "Time-Dependent\nDensity Functional Theory within the\nTamm\u2013Dancoff Approximation",
            "authors": [],
            "year": 1999,
            "venue": "Chem. Phys.\nLett.",
            "volume": "314",
            "issn": "",
            "pages": "291-299",
            "other_ids": {
                "DOI": [
                    "10.1016/S0009-2614(99)01149-5"
                ]
            }
        },
        "BIBREF76": {
            "title": "A New Hybrid\nExchange\u2013Correlation\nFunctional Using the Coulomb-Attenuating Method (CAM-B3LYP)",
            "authors": [],
            "year": 2004,
            "venue": "Chem. Phys. Lett.",
            "volume": "393",
            "issn": "",
            "pages": "51-57",
            "other_ids": {
                "DOI": [
                    "10.1016/J.CPLETT.2004.06.011"
                ]
            }
        },
        "BIBREF77": {
            "title": "Opening the Lid on Piano-Stool Complexes:\nAn Account of Ruthenium(II)\u2013Arene Complexes with Medicinal\nApplications",
            "authors": [],
            "year": 2014,
            "venue": "J. Organomet. Chem.",
            "volume": "751",
            "issn": "",
            "pages": "251-260",
            "other_ids": {
                "DOI": [
                    "10.1016/J.JORGANCHEM.2013.09.016"
                ]
            }
        },
        "BIBREF78": {
            "title": "Long-Range\nCorrected Hybrid Density Functionals with\nDamped Atom\u2013Atom Dispersion Corrections",
            "authors": [],
            "year": 2008,
            "venue": "Phys. Chem. Chem. Phys.",
            "volume": "10",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1039/b810189b"
                ]
            }
        },
        "BIBREF79": {
            "title": "Natural\nTransition Orbitals",
            "authors": [],
            "year": 2003,
            "venue": "J. Chem. Phys.",
            "volume": "118",
            "issn": "",
            "pages": "4775-4777",
            "other_ids": {
                "DOI": [
                    "10.1063/1.1558471"
                ]
            }
        },
        "BIBREF80": {
            "title": "The M06 Suite of Density Functionals for Main Group\nThermochemistry, Thermochemical Kinetics, Noncovalent Interactions,\nExcited States, and Transition Elements: Two New Functionals and Systematic\nTesting of Four M06-Class Functionals and 12 Other Function",
            "authors": [],
            "year": 2008,
            "venue": "Theor. Chem. Acc.",
            "volume": "120",
            "issn": "",
            "pages": "215-241",
            "other_ids": {
                "DOI": [
                    "10.1007/s00214-007-0310-x"
                ]
            }
        },
        "BIBREF81": {
            "title": "Universal\nSolvation Model Based on\nSolute Electron Density and on a Continuum Model of the Solvent Defined\nby the Bulk Dielectric Constant and Atomic Surface Tensions",
            "authors": [],
            "year": 2009,
            "venue": "J. Phys. Chem. B",
            "volume": "113",
            "issn": "",
            "pages": "6378-6396",
            "other_ids": {
                "DOI": [
                    "10.1021/jp810292n"
                ]
            }
        },
        "BIBREF82": {
            "title": "The Localized Electrons Detector\nas an Ab Initio Representation of Molecular Structures",
            "authors": [],
            "year": 2010,
            "venue": "Int. J. Quantum Chem.",
            "volume": "110",
            "issn": "",
            "pages": "a-n",
            "other_ids": {
                "DOI": [
                    "10.1002/qua.22662"
                ]
            }
        },
        "BIBREF83": {
            "title": "Revealing\nNoncovalent Interactions",
            "authors": [],
            "year": 2010,
            "venue": "J. Am. Chem. Soc.",
            "volume": "132",
            "issn": "",
            "pages": "6498-6506",
            "other_ids": {
                "DOI": [
                    "10.1021/ja100936w"
                ]
            }
        },
        "BIBREF84": {
            "title": "Interpretation\nof the Reduced Density Gradient",
            "authors": [],
            "year": 2016,
            "venue": "Mol. Phys.",
            "volume": "114",
            "issn": "",
            "pages": "1406-1414",
            "other_ids": {
                "DOI": [
                    "10.1080/00268976.2015.1123777"
                ]
            }
        },
        "BIBREF85": {
            "title": "Following\nthe Molecular Mechanism for the NH3 + LiH \u2192 LiNH2 + H2 Chemical\nReaction: A Study Based on the Joint Use of the Quantum Theory of\nAtoms in Molecules (QTAIM) and Noncovalent Interaction (NCI) Index",
            "authors": [],
            "year": 2014,
            "venue": "J. Phys. Chem. A",
            "volume": "118",
            "issn": "",
            "pages": "1663-1672",
            "other_ids": {
                "DOI": [
                    "10.1021/jp4111376"
                ]
            }
        },
        "BIBREF86": {
            "title": "A DFT Study on Lignin\nDissolution in Imidazolium-Based Ionic Liquids",
            "authors": [],
            "year": 2017,
            "venue": "RSC Adv.",
            "volume": "7",
            "issn": "",
            "pages": "12670-12681",
            "other_ids": {
                "DOI": [
                    "10.1039/C6RA27059J"
                ]
            }
        },
        "BIBREF87": {
            "title": "Half-Sandwich\nMetal Complexes with \u03b2-Diketone-Like Ligands and Their Anticancer\nActivity",
            "authors": [],
            "year": 2018,
            "venue": "Eur. J. Inorg. Chem.",
            "volume": "2018",
            "issn": "",
            "pages": "3521-3536",
            "other_ids": {
                "DOI": [
                    "10.1002/ejic.201800400"
                ]
            }
        }
    }
}